Human ACE and bradykinin B 2 receptors form a complex at the plasma membrane

Authors:

Abstract
To investigate how angiotensin I‐converting enzyme (ACE) inhibitors enhance the actions of bradykinin (BK) on B 2 receptors independent of blocking BK inactivation, we expressed human somatic ACE and B 2 receptors in CHO cells. Bradykinin and its ACE‐resistant analog were the receptor agonists. B 2 fused with green fluorescent protein (GFP) and ACE were coprecipitated with antisera to GFP or ACE shown in Western blots. Immunohistochemistry of fixed cells localized ACE by red color and B 2 ‐GFP by green. Yellow on plasma membranes of coexpressing cells also indicated enzyme‐receptor complex formation. Using ACE‐fused cyan fluorescent protein donor and B 2 ‐fused yellow fluorescent protein (YFP) acceptor, we registered fluorescence resonance energy transfer (FRET) by the enhanced fluorescence of donor on acceptor photobleaching, establishing close (within 10 nm) positions of B 2 receptors and ACE. Bradykinin stimulation cointernalized ACE and B 2 receptors. We expressed ACE fused to N terminus of B 2 receptors, anchoring only receptors to plasma membranes. Here, in contrast to cells, where both ACE and B 2 receptors are separately anchored, ACE inhibitors neither enhance activation of chimeric B 2 nor resensitize desensitized B 2 receptors. Heterodimer formation between ACE and B 2 receptors can be a mechanism for ACE inhibitors to augment kinin activity at cellular level.—Chen, Z., Deddish, P. A., Minshall, R. D., Becker, R. P., Erdös, E. G., Tan, F. Human ACE and bradykinin B2 receptors form a complex at the plasma membrane. FASEB J. 20, 2261–2270 (2006)
Funding Information
  • National Institutes of Health (HL36473, HL68580)

This publication has 49 references indexed in Scilit: